About ISOLOGIC
Isologic Innovative Radiopharmaceuticals (ISOLOGIC) is a Canadian company dedicated to nuclear medicine and a leader in the production and delivery of high-quality radiopharmaceuticals through our network of SPECT radiopharmacies and PET manufacturing facilities.

Our Mission
To deliver the most clinically relevant PET and SPECT radiopharmaceuticals in a safe and reliable manner allowing Canadian physicians to accurately diagnose, manage and treat disease.

Our Vision
Isologic will strengthen its position as Canada’s leading radiopharmaceutical provider by expanding its geographic reach, fostering strong customer relationships, and driving innovation and research. Through operational excellence and strategic partnerships, we will strive to be Canada’s gateway for novel radiopharmaceuticals, ensuring patient access to novel diagnostic and therapeutic solutions for all Canadians.
Our values guide our daily actions and decisions.

People First
We are committed to fostering a culture of care and respect for our employees while prioritizing the needs of our customers, and their patients.

Quality
We uphold the highest standards of quality in everything we do.

Ethics

Accountability
We take responsibility for our actions and the impact we have on patients.

Health and Safety
We focus on implementing measures that ensure the health and safety of our employees, customers and patients.

Collaboration
We are committed to teamwork and clear communication while transcending organizational and geographical boundaries.

Innovation
We continuously innovate to improve production methods and efficiency to surpass customer expectations.

A message from the President
ISOLOGIC has taken a leadership position in supplying the Canadian nuclear medicine community with clinically relevant radiopharmaceuticals. Our proven success in developing and commercializing innovative imaging agents provides strong evidence of our willingness to bring forward breakthrough radiopharmaceuticals to market.
With state-of-the-art facilities across Canada, and strategic alliances with world-renowned university research hospitals and Nuclear Medicine experts, ISOLOGIC is ready to expand its offering to include the next generation of PET and SPECT radiopharmaceuticals and provide nuclear medicine centres with the most effective diagnostic tools to improve patient care.

André Gagnon
Trusted Quality Care
At Isologic, we offer healthcare professionals peace of mind by ensuring high standards, extensive expertise, and proactive supply management. With over 600,000 doses delivered annually, we guarantee fast, compliant, and reliable service, even during supply shortages.
Our passion drives us to operate 24/7, with a dedicated logistics team and trained professionals who prioritize your needs. We tailor our services to your practice, drawing on deep industry expertise to anticipate and meet the changing needs of clients and patients.
We are committed to delivering high-quality radiopharmaceuticals through rigorous safety protocols, innovative technology, and validated processes. As a trusted partner, we uphold 200+ safety procedures, ensuring every dose meets the highest standards for patient care and clinical excellence.
Leadership team

David Paradis
Vice-President Finance

Annette Proulx
Vice-President of Operations

Frank Maiorino
Vice-President
Commercial Operations

Jeanne Yaourtsakis
Vice-President Human Resources

Vasa Sindolic
Senior Director Cyclotron
and Engineering

Stephane Martin
Sr. Director of CMC / Quality & New
Products Development
Private Sector Partners
Public Sector Partners
Association Affiliations